Anavex Life Sciences Corp (AVXL)

[pcguy]

This may not be a good position for our Excellence trial. If Anavex changed those endpoints for Excellence, they should update now. Saying that endpoint is bad invalidates the endpoint in the much larger and significant trial for children.

Primary Outcome Measures :
RSBQ [ Time Frame: 12 weeks ]
Change from baseline to End of Treatment (EOT) in the Rett Syndrome Behaviour Questionnaire (RSBQ) Total score